This weeks RGH Bulletin looks at
the Clinical issues with the newer
oral anti-coagulants.
The review summarizes key issues
around the novel anticoagulants
now listed on the PBS - and
interestingly concludes that “none
of these novel anticoagulants have
been demonstrated to have clear
advantages relative to warfarin or
low molecular weight heparin.
“People who are well controlled
on warfarin will probably not
benefit from changing to NOAC,” it
adds - CLICK HERE to view.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Sep 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Sep 13
AUSTRALIA needs more pharmacists than ever, in the face of an ageing population and rising healthcare demands, according to the Pharmaceutical Society of Australia (PSA).
INTERN pharmacists from Monash University are set to join Victoria’s immunisation workforce under a new Secretary Approval by the Victorian Health Department.
VIRTUAL care delivered through telephone or video conference has now embedded itself as a core component of healthcare delivery in NSW, new market reports released today have revealed.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.